Not applicableStudy completedNCT03982394What this trial is testingObservational Study of Patients With Moderate to Severe Chronic Plaque PsoriasisWho this might be right forChronic Plaque Psoriasis AbbVie 2,759
Post-approval studies (Phase 4)Study completedNCT00302445What this trial is testingA Safety and Efficacy Study to Evaluate Efalizumab in Combination With UVB for Moderate to Severe PsoriasisWho this might be right forPlaque Psoriasis Derm Research, PLLC 20
Post-approval studies (Phase 4)Study completedNCT00287118What this trial is testingA Multicentre, Open Label Phase IIIb/IV Study of Subcutaneously Administered Raptiva in the Treatment of Adult Subjects With Moderate to Severe Plaque PsoriasisWho this might be right forCandidates for Systemic Therapy for PsoriasisPsoriasis Merck KGaA, Darmstadt, Germany 189
Testing effectiveness (Phase 2)Study completedNCT03025542What this trial is testingEvaluate the Pharmacokinetics (PK), Pharmacodynamics (PD), and Safety of Bimekizumab in Patients With Chronic Plaque PsoriasisWho this might be right forChronic Plaque Psoriasis UCB Biopharma SRL 49
Large-scale testing (Phase 3)Study completedNCT02684370What this trial is testingBI 655066 (Risankizumab) Compared to Placebo and Active Comparator (Ustekinumab) in Patients With Moderate to Severe Chronic Plaque PsoriasisWho this might be right forPsoriasis AbbVie 560
Testing effectiveness (Phase 2)Study completedNCT00678210What this trial is testingEffectiveness and Safety of 3 Dosing Regimens of CP-690,550 to Placebo in Subjects With Moderate to Severe Chronic Plaque PsoriasisWho this might be right forPsoriasis Pfizer 197
Large-scale testing (Phase 3)Looking for participantsNCT07724366What this trial is testingA Clinical Trial of TQH3906 Capsules in Adult Patients With Moderate to Severe Plaque PsoriasisWho this might be right forPsoriasis Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. 400
Testing effectiveness (Phase 2)Looking for participantsNCT07474792What this trial is testingDose Ranging Study of ORKA-002 in Patients With Moderate-to-Severe Plaque PsoriasisWho this might be right forPlaque Psoriasis Oruka Therapeutics, Inc. 160
Large-scale testing (Phase 3)Study completedNCT03624127What this trial is testingEffectiveness and Safety of BMS-986165 Compared to Placebo and Active Comparator in Participants With PsoriasisWho this might be right forPsoriasis Bristol-Myers Squibb 666
Large-scale testing (Phase 3)Study completedNCT03390101What this trial is testingAn International Multicenter, Randomized, Double-blind, Placebo-Controlled Clinical Study of Efficacy and Safety of Two Dosing Regimens of BCD-085 (JSC BIOCAD, Russia) in Patients With Moderate to Severe Plaque PsoriasisWho this might be right forModerate to Severe Plaque Psoriasis Biocad 213
Testing effectiveness (Phase 2)Study completedNCT05190419What this trial is testingStudy to Assess the Efficacy and Safety of Orismilast in PsoriasisWho this might be right forPsoriasisSkin Diseases UNION therapeutics 202
Testing effectiveness (Phase 2)Study completedNCT03858634What this trial is testingAssess the Efficacy, Safety, and Tolerability of KPL-716 in Reducing Pruritus in Chronic Pruritic DiseasesWho this might be right forChronic Idiopathic UrticariaChronic Idiopathic PruritusLichen Planus+2 more Genentech, Inc. 58
Testing effectiveness (Phase 2)Looking for participantsNCT07251998What this trial is testingEfficacy and Safety of ICP-332 Versus Placebo in Participants With Moderate to Severe Plaque PsoriasisWho this might be right forPlaque Psoriasis Beijing InnoCare Pharma Tech Co., Ltd. 172
Large-scale testing (Phase 3)Study completedNCT04839328What this trial is testingA Phase Ⅲ Efficacy and Safety Study of Hemay005 in Subjects With Moderate to Severe Plaque PsoriasisWho this might be right forPsoriasis Tianjin Hemay Pharmaceutical Co., Ltd 306
Testing effectiveness (Phase 2)Study completedNCT02070965What this trial is testingDFD01 Spray vs Comp01 Lotion HPA Axis Suppression Study in Patients With Moderate to Severe Plaque PsoriasisWho this might be right forPlaque Psoriasis Primus Pharmaceuticals 75
Large-scale testing (Phase 3)Study completedNCT03611751What this trial is testingAn Investigational Study to Evaluate Experimental Medication BMS-986165 Compared to Placebo and a Currently Available Treatment in Participants With Moderate-to-Severe Plaque PsoriasisWho this might be right forPsoriasis Bristol-Myers Squibb 1,020
Large-scale testing (Phase 3)Study completedNCT00679731What this trial is testingSafety and Efficacy Comparing ABT-874 Versus Methotrexate in Subjects With Moderate to Severe Plaque PsoriasisWho this might be right forPsoriasis AbbVie (prior sponsor, Abbott) 317
Large-scale testing (Phase 3)Study completedNCT03364309What this trial is testingIxekizumab (LY2439821) in Chinese Participants With Moderate-to-Severe Plaque PsoriasisWho this might be right forPlaque Psoriasis Eli Lilly and Company 438
Post-approval studies (Phase 4)Not Yet RecruitingNCT07373847What this trial is testingVunakizumab Combined With Recaticimab in Subjects With Moderate to Severe Plaque Psoriasis and DyslipidemiaWho this might be right forPlaque Psoriasis Xiangya Hospital of Central South University 40
Not applicableStudy completedNCT01356758What this trial is testingCardiovascular Risk Assessment in Patients With Severe Psoriasis Treated With Biologic AgentsWho this might be right forPsoriasisAtopic DermatitisAtherosclerosis University of Aarhus 126